Literature DB >> 23715651

Percentage of future liver remnant volume before portal vein embolization influences the degree of liver regeneration after hepatectomy.

Hirohisa Okabe1, Toru Beppu, Shigeki Nakagawa, Morikatsu Yoshida, Hiromitsu Hayashi, Toshiro Masuda, Katsunori Imai, Kosuke Mima, Hideyuki Kuroki, Hidetoshi Nitta, Daisuke Hashimoto, Akira Chikamoto, Takatoshi Ishiko, Masayuki Watanabe, Yasuyuki Yamashita, Hideo Baba.   

Abstract

BACKGROUND: Clinical determinants of liver regeneration induced by portal vein embolization (PVE) and hepatectomy remain unclear. The aims of this study were to investigate how liver regeneration occurs after PVE followed by hepatectomy and to determine which factors strongly promote liver regeneration.
METHODS: Thirty-six patients who underwent both preoperative PVE and major hepatectomy were enrolled in this study. Percentage of future liver remnant volume before PVE (%FLR-pre) was compared with the remnant liver volume after PVE (%FLR-post-PVE) and on postoperative day 7 after hepatic resection (%FLR-post-HR). Clinical indicators contributing to liver regeneration induced by both PVE and hepatectomy were examined by logistic regression analysis.
RESULTS: PVE and hepatectomy caused a two-step regeneration. FLR-pre, FLR-post-PVE, and FLR-post-HR were 448, 579, and 761 cm(3), respectively. The %FLR-pre was significantly associated with liver regeneration induced by both PVE and hepatectomy (r = 0.63, p < 0.0001). Multiple regression analysis showed that only %FLR-pre was independently correlated with posthepatectomy liver regeneration (p = 0.027, odds ratio = 13.8).
CONCLUSION: After PVE and the subsequent hepatectomy, liver regeneration was accomplished in a two-step manner. Liver regeneration was strongly influenced by the %FLR-pre.

Entities:  

Mesh:

Year:  2013        PMID: 23715651     DOI: 10.1007/s11605-013-2237-y

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  20 in total

1.  Liver regeneration after major hepatectomy for biliary cancer.

Authors:  M Nagino; M Ando; J Kamiya; K Uesaka; T Sano; Y Nimura
Journal:  Br J Surg       Date:  2001-08       Impact factor: 6.939

Review 2.  Beta-catenin signaling, liver regeneration and hepatocellular cancer: sorting the good from the bad.

Authors:  Kari Nichole Nejak-Bowen; Satdarshan P S Monga
Journal:  Semin Cancer Biol       Date:  2010-12-21       Impact factor: 15.707

3.  Preoperative portal vein embolization (PVE) for patients with hepatocellular carcinoma can improve resectability and may improve disease-free survival.

Authors:  Hirohisa Okabe; Toru Beppu; Takatoshi Ishiko; Toshiro Masuda; Hiromitsu Hayashi; Ryu Otao; Horlad Hasita; Kazutoshi Okabe; Shinichi Sugiyama; Hideo Baba
Journal:  J Surg Oncol       Date:  2011-04-25       Impact factor: 3.454

4.  External biliary drainage and liver regeneration after major hepatectomy.

Authors:  R Otao; T Beppu; T Isiko; K Mima; H Okabe; H Hayashi; T Masuda; A Chikamoto; H Takamori; H Baba
Journal:  Br J Surg       Date:  2012-11       Impact factor: 6.939

5.  Hypertrophy and unconventional cell division of hepatocytes underlie liver regeneration.

Authors:  Yuichiro Miyaoka; Kazuki Ebato; Hidenori Kato; Satoko Arakawa; Shigeomi Shimizu; Atsushi Miyajima
Journal:  Curr Biol       Date:  2012-05-31       Impact factor: 10.834

6.  Early hepatic regeneration index and completeness of regeneration at 6 months after partial hepatectomy.

Authors:  P G Kele; M de Boer; E J van der Jagt; T Lisman; R J Porte
Journal:  Br J Surg       Date:  2012-06-14       Impact factor: 6.939

7.  Preoperative portal vein embolization for extended hepatectomy.

Authors:  Alan W Hemming; Alan I Reed; Richard J Howard; Shiro Fujita; Steven N Hochwald; James G Caridi; Irvin F Hawkins; Jean-Nicolas Vauthey
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

8.  A new approach to percutaneous transhepatic portal embolization using ethanolamine oleate iopamidol.

Authors:  Toru Beppu; Masaaki Iwatsuki; Hirohisa Okabe; Kazutoshi Okabe; Toshiro Masuda; Hiromitsu Hayashi; Shinichi Sugiyama; Kei Horino; Hiroyuki Komori; Naoko Hayashi; Hiroshi Takamori; Takatoshi Ishiko; Hideo Baba
Journal:  J Gastroenterol       Date:  2009-10-10       Impact factor: 7.527

9.  Portal vein embolization before right hepatectomy: prospective clinical trial.

Authors:  Olivier Farges; Jacques Belghiti; Reza Kianmanesh; Jean Marc Regimbeau; Roberto Santoro; Valérie Vilgrain; Alban Denys; Alain Sauvanet
Journal:  Ann Surg       Date:  2003-02       Impact factor: 12.969

10.  Major hepatic resection for hepatocellular carcinoma with or without portal vein embolization: Perioperative outcome and survival.

Authors:  Martin Palavecino; Yun S Chun; David C Madoff; Daria Zorzi; Yoji Kishi; Ahmed O Kaseb; Steven A Curley; Eddie K Abdalla; Jean-Nicolas Vauthey
Journal:  Surgery       Date:  2009-04       Impact factor: 3.982

View more
  9 in total

1.  Remnant growth rate after portal vein embolization is a good early predictor of post-hepatectomy liver failure.

Authors:  Universe Leung; Amber L Simpson; Raphael L C Araujo; Mithat Gönen; Conor McAuliffe; Michael I Miga; E Patricia Parada; Peter J Allen; Michael I D'Angelica; T Peter Kingham; Ronald P DeMatteo; Yuman Fong; William R Jarnagin
Journal:  J Am Coll Surg       Date:  2014-06-25       Impact factor: 6.113

2.  Chronological changes in the liver after temporary partial portal venous occlusion.

Authors:  Koji Hamasaki; Susumu Eguchi; Akihiko Soyama; Masaaki Hidaka; Mitsuhisa Takatsuki; Fumihiko Fujita; Kengo Kanetaka; Shigeki Minami; Tamotsu Kuroki
Journal:  World J Gastroenterol       Date:  2013-09-14       Impact factor: 5.742

Review 3.  Current position of ALPPS in the surgical landscape of CRLM treatment proposals.

Authors:  Marcello Donati; Gregor A Stavrou; Karl J Oldhafer
Journal:  World J Gastroenterol       Date:  2013-10-21       Impact factor: 5.742

4.  Effect of branched-chain amino acid supplementation on functional liver regeneration in patients undergoing portal vein embolization and sequential hepatectomy: a randomized controlled trial.

Authors:  Toru Beppu; Hidetoshi Nitta; Hiromitsu Hayashi; Katsunori Imai; Hirohisa Okabe; Shigeki Nakagawa; Daisuke Hashimoto; Akira Chikamoto; Takatoshi Ishiko; Morikatsu Yoshida; Yasuyuki Yamashita; Hideo Baba
Journal:  J Gastroenterol       Date:  2015-04-08       Impact factor: 7.527

5.  Relationship of immunonutritional factor with changes in liver volume after portal vein embolization.

Authors:  Atsushi Nanashima; Yukinori Tanoue; Koichi Yano; Masahide Hiyoshi; Naoya Imamura; Takeomi Hamada; Kengo Kai; Eiji Kitamura; Yasuto Suzuki; Kousei Tahira; Fumiya Kawano; Takeshi Nagayasu
Journal:  Surg Open Sci       Date:  2022-05-28

6.  Volume regeneration of segments 2 and 3 after right portal vein embolization in patients undergoing two-stage hepatectomy.

Authors:  Yoshihiro Mise; Thomas A Aloia; Claudius Conrad; Steven Y Huang; Michael J Wallace; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2014-08-05       Impact factor: 3.452

7.  A Nomogram to Predict Hypertrophy of Liver Segments 2 and 3 After Right Portal Vein Embolization.

Authors:  Yoshihiro Mise; Guillaume Passot; Xuemei Wang; Hsiang-Chun Chen; Steven Wei; Kristoffer W Brudvik; Thomas A Aloia; Claudius Conrad; Steven Y Huang; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2016-04-12       Impact factor: 3.452

8.  Segment 2/3 Hypertrophy is Greater When Right Portal Vein Embolisation is Extended to Segment 4 in Patients with Colorectal Liver Metastases: A Retrospective Cohort Study.

Authors:  Christopher J Hammond; Saadat Ali; Hafizul Haq; Lorna Luo; Judith I Wyatt; Giles J Toogood; J Peter A Lodge; Jai V Patel
Journal:  Cardiovasc Intervent Radiol       Date:  2019-01-17       Impact factor: 2.740

9.  Evaluation of liver regeneration and post-hepatectomy liver failure after hemihepatectomy in patients with hepatocellular carcinoma.

Authors:  Wen-Feng Gong; Jian-Hong Zhong; Zhan Lu; Qiu-Ming Zhang; Zhi-Yuan Zhang; Chang-Zhi Chen; Xu Liu; Liang Ma; Zhi-Ming Zhang; Bang-De Xiang; Le-Qun Li
Journal:  Biosci Rep       Date:  2019-08-23       Impact factor: 3.840

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.